Overview of Sanofi's Corporate Information
Sanofi, a prominent player in the pharmaceutical sector, is structured as a French société anonyme. This means it operates under strict regulations that maintain transparency and accountability within its governance framework. The company boasts a registered share capital of €2,537,214,304 and has its headquarters at 46, avenue de la Grande Armée, Paris. Sanofi is officially recorded at the Paris Commercial and Companies Registry under the identifier 395 030 844.
Current Voting Rights and Shares
As of October 31, 2024, the total number of issued shares for Sanofi stands at an impressive 1,268,922,721. This number is vital as it underpins the voting rights of shareholders, enabling them to have a say in the company's governance and strategic direction.
Understanding Voting Rights
Voting rights determine the ability of shareholders to influence corporate policies and decisions. For Sanofi, the current count of real voting rights—excluding treasury shares—reaches 1,413,229,859. This figure highlights the active involvement of shareholders in Sanofi's corporate governance.
Theoretical Voting Rights Explained
Moreover, the theoretical number of voting rights, which includes treasury shares, is calculated at 1,428,560,940. This consideration gives a broader view of the voting power among all shareholders, reflecting the total potential influence they can exert on company operations.
Regulatory Compliance
Sanofi adheres to the standards stipulated in article L. 233-8 II of the French Commercial Code and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers. These regulations are in place to ensure that companies provide shareholders with up-to-date information regarding their voting rights and share count.
Accessibility of Information
Transparency is key in maintaining shareholder trust, and Sanofi ensures that this information is easily accessible. Shareholders and potential investors can view this data online. It is a testament to the company’s commitment to keeping its investors informed on matters that directly affect their investment.
Contacting Investor Relations
For any inquiries related to shares and voting rights, interested parties can reach out directly to Sanofi’s Investor Relations Department. They provide important assistance to shareholders who may have questions or require further elucidation on corporate matters.
Final Remarks on Sanofi's Governance
Sanofi’s structured approach to issuing shares and voting rights is essential for fostering a robust corporate governance environment. These practices not only empower shareholders but also support the company’s commitment to ethical business conduct and accountability.
Frequently Asked Questions
What is Sanofi's total issued share count?
As of October 31, 2024, Sanofi has a total of 1,268,922,721 issued shares.
How many real voting rights does Sanofi have?
The number of real voting rights, excluding treasury shares, is 1,413,229,859.
What does the theoretical number of voting rights include?
The theoretical number of voting rights, which includes treasury shares, is 1,428,560,940.
Where can I find more information about Sanofi's shares?
Information about Sanofi's shares can be accessed through their official website under the 'Regulated Information in France' section.
How can I contact Sanofi’s Investor Relations?
Interested parties can contact Sanofi’s Investor Relations Department via email for any inquiries regarding shares and voting rights.
